Nanoparticle therapy in cancer

US10463734B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10463734-B2
Application numberUS-201514695951-A
CountryUS
Kind codeB2
Filing dateApr 24, 2015
Priority dateApr 25, 2014
Publication dateNov 5, 2019
Grant dateNov 5, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Nanoparticles comprising a metal oxide and a platinum cluster having a height to base ratio greater than 1 and compositions containing the same are disclosed. Methods of using the nanoparticles in producing hydroxyl radicals and in photodynamic therapy, for example, in the treatment of hyperproliferative disease such cancer, are also disclosed.

First claim

Opening claim text (preview).

What is claimed: 1. A nanoparticle comprising a metal oxide and a photocathode comprising one or more platinum clusters comprising about 1 to about 100 platinum nanospikes attached to the surface of the metal oxide, wherein each nanospike comprises more than 60 platinum atoms linked by metallic bonding, wherein the platinum cluster has a height to base ratio greater than 1, wherein the metal oxide is tungsten trioxide having an orthorhombic crystal structure. 2. The nanoparticle of claim 1 , wherein the platinum cluster is a co-catalyst in the formation of reactive oxygen species and has a height to base ratio in a range of about 1 to about 2, about 2 to about 4, or about 2.5 to about 5. 3. The nanoparticle of claim 1 , wherein the platinum cluster comprises platinum oxide. 4. The nanoparticle of claim 1 , wherein the crystal structure of the platinum cluster is not cubic. 5. The nanoparticle of claim 1 , wherein the surface-to-volume ratio of the platinum cluster is greater than 1 nm −1 . 6. The nanoparticle of claim 1 , wherein the diameter of the nanoparticle is greater than about 20 nm, optionally about 50 nm to about 60 nm. 7. The nanoparticle of claim 1 , wherein the platinum cluster comprises about 1 to about 100 nanospikes having a base width of about 1 nm to about 10 nm and/or a height of about 5 nm to about 20 nm. 8. The nanoparticle of claim 1 , wherein the platinum cluster comprises a platinum oxide, optionally, PtO, PtO 2 , PtO 3 , or Pt 3 O 4 . 9. A composition comprising the nanoparticle of claim 1 and a pharmaceutically acceptable carrier. 10. A method of making nanoparticles comprising tungsten trioxide and a photocathode comprising one or more platinum clusters comprising about 1 to about 100 nanospikes attached to the surface of the tungsten trioxide, wherein each nanospike comprises more than 60 platinum atoms linked by metallic bonding, wherein the platinum cluster has a height to base ratio greater than 1, said method comprising mixing tungsten trioxide nanoparticles having an orthorhombic structure with chloroplatinic acid to form a mixture, and alkalinizing the mixture to a pH above 10. 11. The method of claim 10 , comprising alkalinizing the mixture to a pH of about 12. 12. A nanoparticle formed using the method of claim 10 . 13. A method of generating reactive oxygen species (ROS) in a cell, comprising irradiating an aqueous solution comprising the cell and the nanoparticle of claim 1 with radiation having a wavelength greater than about 400 nm. 14. A method of photodynamic therapy, comprising administering a therapeutically effective amount of the nanoparticle of claim 1 to a subject in need thereof and irradiating the nanoparticle with radiation having a wavelength greater than about 400 nm. 15. A method of treating cancer in a subject in need thereof comprising administering a therapeutically effective amount of the nanoparticle of claim 1 to the subject and irradiating the nanoparticle with radiation having a wavelength greater than about 400 nm. 16. The method of claim 15 , wherein the cancer is selected from the group consisting of breast cancer, ocular cancer, skin cancer, bladder cancer, esophageal cancer, and lung cancer. 17. The method of claim 15 , wherein the nanoparticle is administered intratumorally, intravenously, intraocularly, topically, or subcutaneously.

Assignees

Inventors

Classifications

  • Oxides · CPC title

  • of ultraviolet wave energy · CPC title

  • Zinc; Compounds thereof · CPC title

  • with inorganic compounds · CPC title

  • involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10463734B2 cover?
Nanoparticles comprising a metal oxide and a platinum cluster having a height to base ratio greater than 1 and compositions containing the same are disclosed. Methods of using the nanoparticles in producing hydroxyl radicals and in photodynamic therapy, for example, in the treatment of hyperproliferative disease such cancer, are also disclosed.
Who is the assignee on this patent?
Univ Michigan Regents
What technology area does this patent fall under?
Primary CPC classification A61K41/0057. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).